Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
2000-01-20
2000-12-05
Jarvis, William R. A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514321, 514327, 514329, A61K 31445
Patent
active
061567698
ABSTRACT:
Anti-pruritic pharmaceutical formulations containing kappa agonist compounds and methods of prevention or treatment of pruritus in a mammal with the anti-pruritic formulations.
REFERENCES:
patent: 4145435 (1979-03-01), Szmuszkovicz
patent: 4359476 (1982-11-01), Kaplan et al.
patent: 4360531 (1982-11-01), McMillan et al.
patent: 4438130 (1984-03-01), Kaplan
patent: 4663343 (1987-05-01), Horwell et al.
patent: 4855316 (1989-08-01), Horwell et al.
patent: 4906655 (1990-03-01), Horwell et al.
patent: 4929627 (1990-05-01), Pannev
patent: 4943578 (1990-07-01), Naylor et al.
patent: 5114945 (1992-05-01), Hayes et al.
Chang An-Chih
Cowan Alan
Farrar John J.
Kumar Virendra
Zhang Wei Yuan
Apolor Corp.
Jarvis William R. A.
Kim Vickie
Villacerta Gilbrath M.
LandOfFree
Kappa agonist anti-pruritic pharmaceutical formulations and meth does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Kappa agonist anti-pruritic pharmaceutical formulations and meth, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Kappa agonist anti-pruritic pharmaceutical formulations and meth will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-962088